OncoDaily: The Impact of Optical Genome Mapping in Cancer Diagnosis
John Herriges is the Assistant Director of the Cytogenetics Laboratory and Associate Program Director of the Genetics and Genomics Fellowship at Children’s Mercy Kansa City. He holds a PhD from the University of Wisconsin and completed fellowships in Laboratory Genetics and Genomics at Children’s Mercy and Clinical Cytogenetics at the University of Utah Medical Center. Dr. Herriges is board certified in both Laboratory Genetics and Genomics and Clinical Cytogenetics.
In this interview with OncoDaily, John Herriges, a specialist in genetics and genomics, shares his insights about the importance of OGM as a comprehensive technique that can detect structural rearrangements throughout the genome while providing detailed information down to the gene level.
What are some of the most significant advancements in genomic testing technologies over the past few years?
In the cancer realm I think that OGM, which has really come to everyone’s attention the last few years, has the potential to be a real gamechanger as it can help streamline testing for patients and can lead to a better genetic classification of tumors. There are a lot of other testing advances though that are significant, like long read sequencing, tumor methylation profiling, and RNA sequencing.
Read the full blog via OncoDaily